IMU PR machine in full swing ...
Watch the replay of our investor webinar held yesterday. During the webinar, Imugene's Managing Director and CEO Leslie Chong, along with Chief Medical Officer Dr. Paul Woodard, discuss the latest data from the azer-cel Phase 1b clinical trial in relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
Watch the full $IMU replay here: https://youtu.be/gAca4R3HCTc #Imugene #AzerCel #CancerResearch #CAR_T #DLBCL #Oncology #ClinicalTrials #InvestorWebinar #Biotech
https://x.com/TeamImugene/status/1831462162604429594
Media Thread, page-15400
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.9¢ | $234.1K | 4.782M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 103 | 14294919 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 635136 | 16 |
View Market Depth
| Last trade - 12.10pm 17/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |